I think the odds are better than even that a cap raise will be required before AHZO expire (probably within the next 12 - 24mths).
I love the tech. however management/Patto lost my trust with the dodgy sales guidance and lackluster divestments/partnerships/cornerstone investors. I'm also still not convinced that costs are under control... let's see what's in the 4C.
Ann: SAVR Clinical Trial, page-21
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |